| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 1671 |
| 1 | LAMIVUDINE ORAL | 1652 |
| 2 | TENOFOVIR DISOPROXIL FUMARATE | 736 |
| 3 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 707 |
| 4 | NEVIRAPINE | 696 |
| 5 | EFAVIRENZ | 676 |
| 6 | ZIDOVUDINE | 568 |
| 7 | ABACAVIR SULFATE | 358 |
| 8 | ABACAVIR | 322 |
| 9 | RALTEGRAVIR | 308 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADEFOVIR DIPIVOXIL | 123 | 0.0968 |
| 1 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 707 | 0.0818 |
| 2 | NEVIRAPINE | 696 | 0.0774 |
| 3 | LAMIVUDINE | 1671 | 0.0661 |
| 4 | EFAVIRENZ | 676 | 0.0609 |
| 5 | RALTEGRAVIR | 308 | 0.0587 |
| 6 | MARAVIROC | 128 | 0.0558 |
| 7 | ZIDOVUDINE | 568 | 0.0548 |
| 8 | ABACAVIR SULFATE | 358 | 0.0367 |
| 9 | ETRAVIRINE | 155 | 0.0349 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 128 | 0.0558 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1313 | 0.0546 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1871 | 0.0381 |
| 3 | Human Immunoglobulin [EPC] | 1 | 0.0196 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2065 | 0.0187 |
| 5 | CD4-directed Blocking Antibody [EPC] | 8 | 0.0148 |
| 6 | Protease Inhibitor [EPC] | 408 | 0.0092 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 387 | 0.0064 |
| 8 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 155 | 0.0030 |
| 9 | Neuraminidase Inhibitor [EPC] | 7 | 0.0028 |